X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs MERCK LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. MERCK LTD WOCKHARDT LTD./
MERCK LTD
 
P/E (TTM) x -15.8 34.2 - View Chart
P/BV x 2.6 3.8 67.7% View Chart
Dividend Yield % 1.3 0.7 172.2%  

Financials

 WOCKHARDT LTD.   MERCK LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
MERCK LTD
Dec-16
WOCKHARDT LTD./
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,1291,060 106.5%   
Low Rs627623 100.6%   
Sales per share (Unadj.) Rs363.1632.4 57.4%  
Earnings per share (Unadj.) Rs-20.445.7 -44.7%  
Cash flow per share (Unadj.) Rs-7.062.3 -11.2%  
Dividends per share (Unadj.) Rs10.0011.00 90.9%  
Dividend yield (eoy) %1.11.3 87.1%  
Book value per share (Unadj.) Rs301.8388.8 77.6%  
Shares outstanding (eoy) m110.5516.60 666.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.41.3 181.7%   
Avg P/E ratio x-42.918.4 -233.3%  
P/CF ratio (eoy) x-125.913.5 -932.1%  
Price / Book Value ratio x2.92.2 134.4%  
Dividend payout %-48.924.1 -203.3%   
Avg Mkt Cap Rs m97,06313,969 694.8%   
No. of employees `0006.81.6 427.5%   
Total wages/salary Rs m9,6651,487 650.1%   
Avg. sales/employee Rs Th5,931.86,631.9 89.4%   
Avg. wages/employee Rs Th1,428.1939.2 152.1%   
Avg. net profit/employee Rs Th-334.0479.4 -69.7%   
INCOME DATA
Net Sales Rs m40,14610,498 382.4%  
Other income Rs m1,143242 471.3%   
Total revenues Rs m41,28910,741 384.4%   
Gross profit Rs m1281,135 11.3%  
Depreciation Rs m1,489276 540.6%   
Interest Rs m2,2530-   
Profit before tax Rs m-2,4721,102 -224.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-211343 -61.5%   
Profit after tax Rs m-2,260759 -297.9%  
Gross profit margin %0.310.8 2.9%  
Effective tax rate %8.531.1 27.4%   
Net profit margin %-5.67.2 -77.9%  
BALANCE SHEET DATA
Current assets Rs m46,1606,410 720.2%   
Current liabilities Rs m19,2588,828 218.1%   
Net working cap to sales %67.0-23.0 -290.8%  
Current ratio x2.40.7 330.1%  
Inventory Days Days10158 174.7%  
Debtors Days Days9438 245.0%  
Net fixed assets Rs m40,1651,406 2,855.9%   
Share capital Rs m553166 333.0%   
"Free" reserves Rs m32,8146,286 522.0%   
Net worth Rs m33,3676,455 517.0%   
Long term debt Rs m31,9030-   
Total assets Rs m89,6878,828 1,015.9%  
Interest coverage x-0.1NM-  
Debt to equity ratio x1.00-  
Sales to assets ratio x0.41.2 37.6%   
Return on assets %08.6 -0.1%  
Return on equity %-6.811.8 -57.6%  
Return on capital %-0.317.1 -2.0%  
Exports to sales %08.3 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA869 0.0%   
Imports (cif) Rs mNA2,209 0.0%   
Fx inflow Rs m9,121959 951.3%   
Fx outflow Rs m2,1332,612 81.7%   
Net fx Rs m6,988-1,653 -422.7%   
CASH FLOW
From Operations Rs m-2,6951,070 -251.7%  
From Investments Rs m-6,863-750 915.4%  
From Financial Activity Rs m12,545-150 -8,374.4%  
Net Cashflow Rs m3,010171 1,761.4%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 2.3 18.2 12.6%  
FIIs % 7.7 1.0 770.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 29.1 52.9%  
Shareholders   67,757 28,591 237.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS